Regulus Therapeutics
Insider trading & Transactions

Last updated: 29 Oct 2014

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Option	29 Oct 2014	GIBSON NEIL W officer: Chief Scientific Officer officer: Chief Scientific Officer	Common Stock	2,500	N/A	N/A
Option	29 Oct 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Common Stock	3,505	N/A	N/A
Sale	29 Oct 2014	GIBSON NEIL W officer: Chief Scientific Officer officer: Chief Scientific Officer	Common Stock	2,500	N/A	N/A
Option	29 Oct 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Stock Option (Right to Buy)	3,505	N/A	N/A
Sale	24 Oct 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	3,254	N/A	N/A
Sale	24 Oct 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	3,254	N/A	N/A
Sale	23 Oct 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	3,350	N/A	N/A
Sale	23 Oct 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	3,350	N/A	N/A
Sale	22 Oct 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	218,893	N/A	N/A
Sale	22 Oct 2014	GIBSON NEIL W officer: Chief Scientific Officer officer: Chief Scientific Officer	Common Stock	3,300	N/A	N/A
Option	22 Oct 2014	GIBSON NEIL W officer: Chief Scientific Officer officer: Chief Scientific Officer	Common Stock	3,300	N/A	N/A
Sale	22 Oct 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	218,893	N/A	N/A
Option	22 Oct 2014	GIBSON NEIL W officer: Chief Scientific Officer officer: Chief Scientific Officer	Stock Option (Right to Buy)	3,300	N/A	N/A
Option	20 Oct 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Common Stock	300	N/A	N/A
Option	20 Oct 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Stock Option (Right to Buy)	300	N/A	N/A
Sale	20 Oct 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Common Stock	300	N/A	N/A
Option	17 Oct 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Stock Option (Right to Buy)	400	N/A	N/A
Sale	17 Oct 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Common Stock	400	N/A	N/A
Sale	17 Oct 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	3,000	N/A	N/A
Sale	17 Oct 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	3,000	N/A	N/A
Option	17 Oct 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Common Stock	400	N/A	N/A
Sale	16 Oct 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	4,800	N/A	N/A
Sale	16 Oct 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	4,800	N/A	N/A
Sale	15 Oct 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	4,300	N/A	N/A
Sale	15 Oct 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	4,300	N/A	N/A
Option	14 Oct 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Stock Option (Right to Buy)	400	N/A	N/A
Sale	14 Oct 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Common Stock	400	N/A	N/A
Option	14 Oct 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Common Stock	400	N/A	N/A
Sale	10 Oct 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	2,000	N/A	N/A
Sale	10 Oct 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	2,000	N/A	N/A
Sale	9 Oct 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	4,750	N/A	N/A
Sale	9 Oct 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	4,750	N/A	N/A
Option	9 Oct 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Common Stock	105	N/A	N/A
Sale	9 Oct 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Common Stock	105	N/A	N/A
Option	9 Oct 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Stock Option (Right to Buy)	105	N/A	N/A
Sale	8 Oct 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	3,300	N/A	N/A
Sale	8 Oct 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	3,300	N/A	N/A
Sale	3 Oct 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	3,300	N/A	N/A
Sale	3 Oct 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	3,300	N/A	N/A
Sale	2 Oct 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	3,750	N/A	N/A
Sale	2 Oct 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	3,750	N/A	N/A
Sale	1 Oct 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	3,250	N/A	N/A
Sale	1 Oct 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	3,250	N/A	N/A
Option	30 Sep 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Common Stock	2,300	N/A	N/A
Sale	30 Sep 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Common Stock	2,300	N/A	N/A
Option	30 Sep 2014	XANTHOPOULOS KLEANTHIS G director, officer: President and .. director, officer: President an..	Stock Option (Right to Buy)	2,300	N/A	N/A
Sale	26 Sep 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	2,500	N/A	N/A
Sale	26 Sep 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	2,500	N/A	N/A
Sale	25 Sep 2014	ISIS PHARMACEUTICALS INC 10 percent owner 10 percent owner	Common Stock	2,500	N/A	N/A
Sale	25 Sep 2014	ALNYLAM PHARMACEUTICALS, INC. 10 percent owner 10 percent owner	Common Stock	2,500	N/A	N/A

Showing 200 to 250 of 397 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Regulus Therapeutics Insider trading & Transactions

Insider trading

Who is insider?

Similar companies insider trading:

Regulus Therapeutics
Insider trading & Transactions